Viewing Study NCT07150767

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-01-04 @ 7:59 PM
Study NCT ID: NCT07150767
Status: WITHDRAWN
Last Update Posted: 2025-12-02
First Post: 2025-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer
Sponsor: Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Breast Cancer (LABC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) View